Vaxxas
Developer of a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. The company's system consists of an array of vaccine-coated microprojec...
Valuation
$235.6M
Market implied
Share Price
N/A
Total Raised
$154.3M
Last Round
N/A